+987.9%
MRNA vs VEU
+17.0%
+970.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VEU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +2.0% | +11.1% | +9.3% |
| 7D | +20.6% | +0.2% | +20.4% | +20.4% |
| 30D | +27.1% | -2.1% | +29.3% | +33.2% |
| 3M | +353.4% | -2.7% | +356.1% | +386.2% |
| 6M | +446.3% | +3.2% | +443.1% | +439.4% |
| YTD | +776.2% | +12.6% | +763.6% | +625.4% |
| 1Y | +987.9% | +17.1% | +970.8% | +704.0% |
| All | +987.9% | +17.0% | +970.9% | +704.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VEU.
Daily Out/Under-Performance
Portfolio return minus VEU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling